Tilray Brands Stock Surges 27% Amid Cannabis Reclassification Speculation

Tilray Brands (TLRY) shares skyrocketed 27.5% to $13.94 on December 16, fueled by unprecedented trading volume exceeding 47 million shares—721% above average. The rally coincides with renewed political momentum for cannabis reform, as former President TRUMP hinted at potential reclassification of marijuana from Schedule I to III.

Market sentiment shifted dramatically, with analysts upgrading Tilray from 'strong sell' to 'hold' and setting a $20 price target. The stock has gained over 60% in five sessions, reflecting growing institutional confidence in the sector. Tilray's financial health—marked by a 0.15 debt-to-equity ratio and 1.56 quick ratio—positions it as a bellwether for the cannabis industry's maturation.

'The green rush is real,' tweeted HanfTicker, capturing the market's euphoria. While regulatory uncertainty persists, the prospect of federal reclassification has ignited what some traders call a 'second wave' of cannabis investment.